| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/18/2002 | US20020094960 Specifically unipolar depression, treatment-refractory depression, resistant depression, anxious depression and dysthymia; 2-sulfamatomethyltetrahydropyrans and sulfamato-methylcyclohexanes, e.g. topiramate |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1) |
| 07/18/2002 | US20020094347 A neuro-active molecule, other than dopamine, within a microsphere comprising a biocomatible polymer having kinetic characteristics that may be manipulated to allow for the permeation of drug through polymer at controlled rate |
| 07/18/2002 | US20020094335 Treating amyloid-related disease in subject by administering antigenic amount of all-D peptide, wherein peptide elicits production of antibodies against peptide and induces an immune response |
| 07/18/2002 | US20020094318 Dispersible dry powder of a therapeutic agent such as insulin with an aerogel particle which is soluble in human pulmonary surfactant, such as sugars and carbohydrates |
| 07/18/2002 | DE10102053A1 Piperazinylcarbonyl-quinoline and piperazinylcarbonyl-isoquinoline derivatives useful for treatment of e.g. schizophrenia, psychoses, depression, Parkinson's disease and Alzheimer's disease |
| 07/18/2002 | DE10102048A1 Use of active antithrombin III having endothelial cell proliferation inhibitory activity for combating diseases associated with angiogenesis, e.g. retinopathy, neuropathy, leprosy and cancer |
| 07/18/2002 | DE10101917A1 Verwendung von Chromanen Use of chromans |
| 07/18/2002 | DE10064312A1 Cholinpyruvat, Verfahren zu dessen Herstellung, Cholinpyruvat enthaltende Formulierung sowie deren Verwendung Choline pyruvate, containing process for the production thereof, choline pyruvate formulation and the use thereof |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2697520A1 Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 07/18/2002 | CA2436811A1 Use of chromanes for treating parkinson's disease |
| 07/18/2002 | CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | CA2434152A1 Therapeutic heterocyclic compounds |
| 07/18/2002 | CA2434015A1 Therapeutic chroman compounds |
| 07/18/2002 | CA2434006A1 Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists |
| 07/18/2002 | CA2434005A1 Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists |
| 07/18/2002 | CA2433997A1 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 07/18/2002 | CA2433950A1 Therapeutic chromone compounds |
| 07/18/2002 | CA2433720A1 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 07/18/2002 | CA2433687A1 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | CA2433623A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | CA2433084A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | CA2432350A1 Method for inhibiting the expression of a target gene |
| 07/18/2002 | CA2430588A1 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | CA2429177A1 Inhibition of nf-.kappa.b by triterpene compositions |
| 07/18/2002 | CA2428497A1 Targeted modification of intracellular compounds |
| 07/18/2002 | CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | CA2395711A1 Pharmaceutical compositions |
| 07/17/2002 | EP1223176A2 Peptide mutant of human ERAB/HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1222925A2 Kavalactone as TNF-alpha production inhibitor |
| 07/17/2002 | EP1222920A2 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1222302A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 07/17/2002 | EP1222284A2 22196, a novel human aminopeptidase |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222265A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 07/17/2002 | EP1222259A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222206A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 07/17/2002 | EP1222203A1 Method of altering polypeptide aggregation |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222188A1 Novel imidazopyridine carbonitrile compounds |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP1222185A1 Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists |
| 07/17/2002 | EP1222183A1 Benzopyran derivatives |
| 07/17/2002 | EP1222176A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| 07/17/2002 | EP1222170A1 Novel nicotinonitrile compounds |
| 07/17/2002 | EP1222169A1 Novel trisubstituted pyridine compounds |
| 07/17/2002 | EP1222162A1 Novel ltb 4? antagonist, method for the production thereof and its use as a medicament |
| 07/17/2002 | EP1221975A2 Polymer stabilized neuropeptides |
| 07/17/2002 | EP1221973A1 CD40 antagonist for treating psoriasis |
| 07/17/2002 | EP1221958A1 Analgesic from snake venom |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221953A1 Treating sleep disorders using desloratadine |
| 07/17/2002 | EP1221952A1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 07/17/2002 | EP1221950A1 Synergistic combinations of an nk 1? receptor antagonist and a gaba structural analog |
| 07/17/2002 | EP1221944A1 Oral dosage form comprising a salt of morphine or a morphine derivative |
| 07/17/2002 | EP1221941A1 Powder pharmaceutical formulations |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP1221853A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 07/17/2002 | EP1049670B1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0851865B1 12H-Dibenzo[d,g][1,3]dioxocine derivatives |
| 07/17/2002 | EP0828494B1 Method for treating cognitive dysfunction |
| 07/17/2002 | CN1359382A Method for preparing citalopram |
| 07/17/2002 | CN1359378A 2-oxy-benzoxazine derivatives for the treatment of obesity |
| 07/17/2002 | CN1359375A Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same |
| 07/17/2002 | CN1359303A Pharmaceutical complex |
| 07/17/2002 | CN1359301A Prevention and treatment of amyloidogenic disease |
| 07/17/2002 | CN1359296A Use of xenon for treating neurointoxications |
| 07/17/2002 | CN1359295A Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 07/17/2002 | CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel |
| 07/17/2002 | CN1359289A Selective iGLuR5 receptor antagonists for the treatment of migraine |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1358543A Recombination plasmid and application in disease prevention and control |
| 07/17/2002 | CN1358530A Litholytic medicine for treating hepatolith and preparation process thereof |
| 07/17/2002 | CN1358508A Capsule for tonifying kidney and tranquilization |
| 07/17/2002 | CN1358505A Capsule for treating headache |
| 07/17/2002 | CN1358504A Huishen pill |
| 07/17/2002 | CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420600 Hydroxyalkylphenyldiamides |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420574 Reacting 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile with substituted alkyl halide/sulfonate; chemical intermediate converted to amine; antidepressant; avoids by-product formation |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420426 Used to treat complications from diabetes mellitus |
| 07/16/2002 | US6420420 Method for increasing the concentration of ascorbic acid in brain tissue of a subject |
| 07/16/2002 | US6420416 Administering nefiracetam |
| 07/16/2002 | US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds |